An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Research Publications (Food Safety)

This page tracks research articles published in national and international peer-reviewed journals. Recent articles are available ahead of print and searchable by Journal, Article Title, and Category. Research publications are tracked across six categories: Bacterial Pathogens, Chemical Contaminants, Natural Toxins, Parasites, Produce Safety, and Viruses. Articles produced by USDA Grant Funding Agencies (requires login) and FDA Grant Funding Agencies (requires login) are also tracked in Scopus.

Displaying 1 - 4 of 4

  1. Evaluation of hydrogen peroxide efficacy against AZD1222 chimpanzee adenovirus strain in the recombinant COVID‐19 vaccine for application in cleaning validation in a pharmaceutical manufacturing industry

    • Letters in Applied Microbiology
    • Letters in Applied Microbiology, EarlyView.

      • Viruses
      • COVID-19
  2. Tea crude extracts effectively inactivate severe acute respiratory syndrome coronavirus 2

    • Letters in Applied Microbiology
    • Letters in Applied Microbiology, Volume 74, Issue 1, Page 2-7, January 2022.

      • Viruses
      • COVID-19
  3. Probiotics and COVID‐19: is there any link?

    • Letters in Applied Microbiology
    • Significance and Impact of the Study: The role of probiotics in alleviation of the novel COVID‐19 has not been established. This review provides an insight about the anti‐inflammatory, antiviral effects of probiotics in vitro, animal models and human. The latter can provide an indirect evidence and/or hypothesis‐driven approach to investigate the use of probiotics as adjunctive therapy in the prophylaxis and/or alleviation of COVID‐19 symptoms.

      • Viruses
      • COVID-19
  4. BCG vaccination early in life does not improve COVID‐19 outcome of elderly populations, based on nationally reported data

    • Letters in Applied Microbiology
    • Significance and Impact of the Study: It has been suggested in the recent literature that some countries have lower case rates or death rates of Covid‐19 as a result of large‐scale BCG vaccination programs. This has resulted in the initiation of clinical trials to assess if the vaccine can act as a prophylactic or ameliorate the disease.

      • Viruses
      • COVID-19